BIOMAT Database Logo BIOMAT Database Logo

[Obesity and thyroid hormone therapy]. 1970

K Naess

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013954 Thyroglobulin

Related Publications

K Naess
Thyroid hormone and obesity.
October 2012, Current opinion in endocrinology, diabetes, and obesity,
K Naess
Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review.
October 2009, The Journal of clinical endocrinology and metabolism,
K Naess
[Thyroid gland function in obesity and effect of thyroid hormone therapy in fasting subjects].
January 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
K Naess
Glucagon-modified Liposomes Delivering Thyroid Hormone for Anti-obesity Therapy.
June 2023, Archives of medical research,
K Naess
Thyroid hormone metabolism in obesity.
June 2000, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
K Naess
[Thyroid hormone therapy].
December 1978, Soins; la revue de reference infirmiere,
K Naess
[Thyroid hormone therapy].
March 2000, Der Internist,
K Naess
Thyroid hormone therapy.
January 1958, The Practitioner,
K Naess
Thyroid hormone therapy.
September 1975, The Medical clinics of North America,
K Naess
Quantifying Thyroid Hormone Resistance in Obesity.
June 2020, Obesity surgery,
Copied contents to your clipboard!